A client taking alosetron reports new constipation and cramp… | MyMerci
Adverse Effects/Contraindications/Interactions PPT
Question

A client taking alosetron reports new constipation and cramping lower abdominal pain. What should the nurse instruct the client to do?

Explanation
Alosetron must be stopped immediately when constipation or signs of ischemic colitis develop. Serious bowel complications can occur without waiting for rectal bleeding.
Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Use new constipation or ischemic-colitis cues as an alosetron stop rule.

Why this is correct
Continuing the drug or adding another bowel-slowing agent can worsen obstruction or ischemia.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: LOTRONEX (alosetron)Immediate discontinuation for constipation or ischemic-colitis symptoms

Clinical scenario

Medication-safety review
Verify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.